Salix announced that the FDA has approved Fulyzaq (crofelemer) delayed-release tablets for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy ...
A 32-year-old man with type 2 diabetes, hypertension, and gastroesophageal reflux disease reports yellow diarrhea on a daily basis. He recently had his gallbladder removed. An earlier trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback